General Information of the Protein
Protein ID
PT00985
Protein Name
Cell division cycle 7-related protein kinase
Gene Name
CDC7
Secondarily
Gene Name
CDC7L1
Sequence
MEASLGIQMDEPMAFSPQRDRFQAEGSLKKNEQNFKLAGVKKDIEKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKSHIITGNKIPLSGPVPKELDQQSTTKASVKRPYTNAQIQIKQGKDGKEGSVGLSVQRSVFGERNFNIHSSISHESPAVKLMKQSKTVDVLSRKLATKKKAISTKVMNSAVMRKTASSCPASLTCDCYATDKVCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHASHQPAISEKTDHKASCLVQTPPGQYSGNSFKKGDSNSCEHCFDEYNTNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMSL
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Kinase
>
Protein Kinase
>
Other protein kinase group
>
Other protein kinase CDC7 family
Function
Kinase involved in initiation of DNA replication. Phosphorylates critical substrates that regulate the G1/S phase transition and initiation of DNA replication, such as MCM proteins and CLASPIN.
    Show/Hide
Uniprot ID
Primary ID:
O00311

Secondarily ID:
D3DT31
O00558
Q5T5U5
    Show/Hide
Ensembl ID
ENSG00000097046
HGNC ID
HGNC:1745
Subcellular Location
Nucleus
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000034 , Caco-2
Compound ID Compound Name Compound Formula
CP0029051
8-chloro-2-[(2S)-pyrrolidin-2-yl]-3H-[1]benzofuro[3,2-d]pyrimidin-4-one
   Show/Hide
C14H12ClN3O2
 1
1
IC50 = 140 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0182411
4-[3-(2-chloropyridin-3-yl)pyrrolo[3,2-c]pyridin-1-yl]pyrimidin-2-amine
   Show/Hide
C16H11ClN6
 1
1 IC50 = 7 nM
CP0143129
1-(6-aminopyrimidin-4-yl)pyrrolo[2,3-b]pyridine-6-carbonitrile
   Show/Hide
C12H8N6
 1
1 IC50 = 9 nM
CP0244947
4-[6-chloro-3-(2-chloropyridin-3-yl)pyrrolo[3,2-c]pyridin-1-yl]pyrimidin-2-amine
   Show/Hide
C16H10Cl2N6
 1
1 IC50 = 30 nM
CP0131377
1-(2-aminopyrimidin-4-yl)indole-6-carbonitrile
   Show/Hide
C13H9N5
 1
1 IC50 = 75 nM
CP0143166
4-(6-chloropyrrolo[3,2-c]pyridin-1-yl)pyrimidin-2-amine
   Show/Hide
C11H8ClN5
 1
1 IC50 = 360 nM
CP0182408
4-indol-1-ylpyrimidin-2-amine
   Show/Hide
C12H10N4
 1
1 IC50 = 4700 nM
CP0233225
1-(2-aminopyridin-4-yl)indole-6-carbonitrile
   Show/Hide
C14H10N4
 1
1 IC50 = 9000 nM
CP0282146
4-pyrrolo[2,3-b]pyridin-1-ylpyrimidin-2-amine
   Show/Hide
C11H9N5
 1
1 IC50 = 26700 nM
CP0179612
Simurosertib
   Show/Hide
C17H19N5OS
 1
1 Kd = 0.424 nM
CP0238038
6-(5-methyl-1H-pyrazol-4-yl)-2-(pyrrolidin-1-ylmethyl)-3H-thieno[3,2-d]pyrimidin-4-one
   Show/Hide
C15H17N5OS
 1
1 Kd = 0.541 nM
CP0202830
6-(5-methyl-1H-pyrazol-4-yl)-2-[(2S)-piperidin-2-yl]-3H-thieno[3,2-d]pyrimidin-4-one;dihydrochloride
   Show/Hide
C15H19Cl2N5OS
 1
1 Kd = 1.96 nM
Clinical Information about the Protein
Target 1 ( CDC7-related kinase (CDC7) )
Target Type Clinical trial Target
Disease 2 Target-related Diseases  2
1 Haematological malignancy [ICD-11: 2B33.Y]
2 Solid tumour/cancer [ICD-11: 2A00-2F9Z]
Clinical Trial Drug(s) 2 Clinical Trial Drugs  2
1 BMS-863233 Phase 1/2
Haematological malignancy
2 TAK-931 Phase 1
Solid tumour/cancer